The global nicotine transdermal patches market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The major factor driving the demand for the global nicotine transdermal patches market during the forecast period is the increasing awareness of the benefits of using nicotine transdermal patches across the globe. Nicotine is beneficial for people who want to quit smoking. According to the National Centre for Biotechnology Information (NCBI), using nicotine transdermal patches can treble the number of people who quit smoking. Additionally, as per the same source, in clinical research involving 500 patients, 13% of those who used nicotine transdermal patches were successful in quitting smoking. Furthermore, these patches also help smokers enhance their coordination, response time, and attentiveness, as well as their short-term memory. Moreover, the growing number of advertising programs and activities for smoking cessation aids is expected to drive the global nicotine transdermal patches market. To raise awareness, organizations are launching and conducting anti-smoking programs and initiatives. Smoking cessation aids such as nicotine transdermal patches, e-cigarettes, and vaping devices are gaining popularity among consumers, which will drive market growth in the coming years. 

Impact of COVID-19 Pandemic on Global Nicotine Transdermal Patches Market

The COVID-19's rapid appearance led to the implementation of strong lockdown measures in several countries, having a significant impact on the global nicotine transdermal patch business. People were forced to stay at home due to the lockdown, and many used this as a chance to quit smoking. During the shutdown, nicotine transdermal patches were in high demand, which helped the industry flourish. Furthermore, several researchers found that using nicotine could help prevent COVID-19 infection, as active smokers were less likely to have instances of the virus. Overall, the global nicotine transdermal patches market grew significantly following COVID-19, owing to an increase in the number of people using nicotine transdermal patches.

Segmental Outlook 

The global nicotine transdermal patches market is segmented based on the type and application. Based on the type, the market is sub-segmented into 21mg/patch, 14mg/patch, and 7mg/patch. Based on the application, the market is sub-segmented into age below 30, age 30-50, and age above 50. The 21mg/patch nicotine transdermal patches segment is anticipated to hold a prominent share in the market during the forecast period. The 21mg/patch is more successful in reducing smoking urges' positive reinforcing component. 

Global Nicotine Transdermal Patches Market Share by Application, 2021 (%)

The Age 30-50 Segment is Anticipated to Hold a Prominent Share in the Global Nicotine Transdermal Patches Market

The Age 30-50 Segment is Anticipated to hold a prominent share in the global nicotine transdermal patches owing to the increasing demand for nicotine patches by the people in this segment. People in-between the age of 30-50 is the most desired persons who want to quit smoking as fast as they can. The maximum sales of nicotine transdermal patches are done in these age groups globally. This helps the market to grow in a significant way as more and more people gain access to these patches. For instance, in 2019, 163 patients (19.4%) quit smoking who used nicotine patches and 99 patients (11.7%) who used placebo patches, according to a PubMed.gov study of 1,686 heavy smokers aged 30-50 years. The study concluded that using a nicotine patch to quit smoking is effective.

Regional Outlooks

The global nicotine transdermal patches market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America. During the forecast period, North America is expected to witness a significant market expansion. The region is expected to hold a prominent share in the market owing to the high awareness levels of nicotine de-addiction products. The large market share can also be achieved due to the established healthcare infrastructure and the rising disposable income.

Global Nicotine Transdermal Patches Market Growth, by Region 2022-2028 

The Asia-Pacific region is estimated to Hold a prominent Share in the Global Nicotine Transdermal Patches Market

The Asia-Pacific is anticipated to hold a prominent share in the market due to an increase in the numbers of active smokers every day with ongoing promotional activities done by the brands. The age at which people get addicted to smoking in the Asia-Pacific region is quite small, and with such a huge population, active smokers make boost the nicotine transdermal patches market. Additionally, government initiatives regarding awareness about the ill effects of smoking reduce smoking habits. As a result of this trend, vendors are concentrating their efforts on launching new items regularly and expanding their customer base in the Asia-Pacific region.

Market Players Outlook

The major companies serving the global nicotine transdermal patches market include Cigna Corp., Dr Reddy’s Laboratories Ltd., GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Novartis International AG, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2018, GlaxoSmithKline plc announced that it has reached an agreement with Novartis for the buyout of Novartis’ 36.5% stake in their Consumer Healthcare Joint Venture for $13 billion. The joint venture sells products such as Nicotinell nicotine patches, Panadol headache tablets and Sensodyne toothpaste.

The Report Covers

• Market value data analysis of 2021 and forecast to 2028.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global nicotine transdermal patches market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.